TICO
Showing 1 - 9 of 9
COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)
Completed
- COVID-19
- LY3819253
- +2 more
-
Tucson, Arizona
- +56 more
Mar 22, 2023
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)
Completed
- COVID-19
- VIR-7831
- +2 more
-
Tucson, Arizona
- +104 more
Mar 22, 2023
COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)
Active, not recruiting
- COVID-19
- AZD7442
- +2 more
-
Tucson, Arizona
- +123 more
Mar 24, 2023
Mental Stress, Emotional Stress Trial in Richmond (TICM, TICO)
Withdrawn
- Mental Stress
- Emotional Stress
- TICM
- TICO
-
Richmond, VirginiaVirginia Commonwealth University
Nov 26, 2018
Acute Coronary Syndrome Trial in Seoul (Ticagrelor monotherapy, Ticagrelor with Aspirin DAPT(dual antiplatelet treatment))
Recruiting
- Acute Coronary Syndrome
- Ticagrelor monotherapy
- Ticagrelor with Aspirin DAPT(dual antiplatelet treatment)
-
Seoul, Korea, Republic ofDivision of Cardiology, Department of Internal Medicine, Yonsei
Jun 19, 2018
HIV Infection, Hepatitis B Coinfection Trial in Darlinghurst, Melbourne, Bangkok (Tenofovir, Zidovudine (AZT), lamivudine (LAM),
Completed
- HIV Infection
- Hepatitis B Coinfection
- Tenofovir
- Zidovudine (AZT), lamivudine (LAM), efavirenz (EFV)
-
Darlinghurst, New South Wales, Australia
- +2 more
Mar 30, 2015